The device comes with multiple physiological and environmental sensors designed to measure signals connected to cardiovascular, movement disorders and more
Verily, an Alphabet-owned company, has unveiled a new health-focused wearable. Called the Study Watch, the device is aimed at offering data beyond what is available in current generation wearables. In its official blog, the company says that the device offers a “scalable collection of rich and complex datasets across clinical and observational studies.”
The device comes with multiple physiological and environmental sensors designed to measure signals connected to cardiovascular, movement disorders and more. These include electrocardiogram (ECG), heart rate, electrodermal activity, and inertial movements. Further, it is also said to offer large internal storage in order to store weeks worth of data. This would reduce the need for the user to frequently sync the device.
Other features of the wearable include a battery life of up to a week, as well as a powerful processor for real-time algorithms on the the device. It also sports a low power, high resolution display, which always shows the time. The firmware of the wearable is designed to allow for OTA updates, new algorithms and UI upgrades.
However, Verily has stated that the Study Watch is not for sale, so the average user will not be able to purchase it. The device will be used for observational studies conducted by Verily’s partners like the Personalized Parkinson’s Project. It will also be used in an upcoming study called Baseline, which aims to collect data from multiple individuals, in order to learn more about the human body and detect diseases earlier.
Alphabet isn’t the company working on devices focused on health. Last week, it was reported that Apple may be working on a secret project to non-invasively and continuously monitor blood sugar levels to better treat diabetes.
Follow Us
Shrey Pacheco
Writer, gamer, and hater of public transport. View Full Profile
